R&D

This is the latest episode of the free DDW narrated podcast, “Challenges and tactics for transformative drug development”. It covers two articles written for Volume 23, Issue 2 – Spring 2022 of DDW. They are called “Balancing speed and quality in CLD for faster drug development”, and “Sitting down with BridgeBio Pharma”. In the first article, Soojin Han, Chief Technical Lead […]

A cloud-based digital pathology platform has helped a CRO deliver more informed preclinical studies.  Proscia announced that Virscio, a provider of translational research and development services, has deployed Concentriq for Research.   Context  90% of drug candidates fail during clinical trials.1 This negatively impacts R&D efficiency, as measured by the number of new drugs approved relative […]

This is the latest episode of the free DDW podcast, “Complex problems require complex solutions”. It covers two articles written for Volume 23, Issue 1 – Winter 2021/22 of DDW. They are called “How quantum computing can benefit drug discovery” and “Sitting down with Dr Michael Hayden from Prilenia Therapeutics”. In the first article, Brad […]

The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D, has launched a new Community of Experts (CoE) with the aim of harnessing real-world data (RWD) from social media. The organisation is calling on technology companies, data scientists and RWD experts to join the community.  The CoE aims to […]

A new partnership will bring together Microsoft’s computational services, cloud and artificial intelligence (AI) and Novo Nordisk’s drug discovery, development and data science capabilities. Through the agreement, Microsoft will provide AI technology, foundational science models and expertise and work alongside Novo Nordisk’s data scientists and domain experts to accelerate the company’s R&D. “The collaboration with […]

BioIVT has acquired XenoTech, a provider of products and services for preclinical testing that specialises in ADME, DMPK and DDI testing of potential drug candidates.  Through the acquisition, BioIVT aims to expand the portfolio of research models and services that are available to its clients to support their R&D function.   “XenoTech has a well-established and excellent reputation […]

Benchling has launched its first full set of capabilities for designing, modeling, and studying both natural and chemically modified RNA in a single solution. As the biopharmaceutical industry increases its focus on developing RNA therapeutics, the new RNA solution could help R&D organisations accelerate the delivery of drug candidates. Following the successful deployment of RNA […]

Merck has opened a new Launch and Technology Center for healthcare in Darmstadt, costing the company around €160 million. This is part of a planned investment of more than €1.5 billion at the global headquarters in Darmstadt by 2025. The Launch and Technology Center will bridge research and commercial production and will enable the company […]

Listen to this article on the DDW Podcast: Michael Henderson, MD, Chief Business Officer of BridgeBio Pharma, tells Lu Rahman about the company’s pursuit of transformative medicines to treat genetic diseases. BridgeBio’s mission is to discover, create, test and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers […]

AstraZeneca has launched a global R&D Postdoctoral Challenge to help accelerate ideas to transform the treatment of some of the world’s most complex diseases. Successful proposals will secure fully funded postdoctoral research positions. The challenge The challenge, launched at EXPO 2020 Dubai, invites final year MD and/or PhD students and postdoctoral researchers from across the […]

Listen to this article on the DDW Podcast: Dr Michael Hayden’s early encounters and experience with patients and families suffering from Huntington’s Disease has had a significant personal impact that shaped his career. As CEO of Prilenia Therapeutics, he tells Lu Rahman why he has dedicated his career to advancing research into this and other neurodegenerative […]

Ashu Singhal, President & Co-Founder of Benchling, shares newly heightened expectations for the biotechnology industry following the developments of the last 18 months.   The last 18 months have heightened expectations for the biotechnology industry. Scientists came together to develop vaccines at record speeds and set the tone for future scientific research. In this new era of […]

Sanofi will acquire Origimm Biotechnology in December 2021, an Austrian biotechnology company specialising in the discovery of virulent skin microbiome components and antigens from bacteria-causing skin disease (such as acne), adding ORI-001 to Sanofi’s early-stage pipeline.  What is ORI-001?  ORI-001 is a therapeutic vaccine candidate for acne vulgaris based on recombinant proteins, which entered preliminary clinical studies in Q3 […]

A new brochure by Sartorius is now available to download.   Vaccination is the most effective method of preventing infectious diseases, and is considered one of the greatest achievements in medicine. Until today, various vaccines against several crucial diseases (including influenza, chicken pox, or HPV) have been developed that save millions of lives.   The continuous emergence of new […]

Dr Steve Arlington, President of The Pistoia Alliance, has called on the pharmaceutical industry to continue building on the advances in collaboration it has built over the past two years. Digital transformation has accelerated rapidly during the pandemic, which in turn has greatly improved remote patient monitoring, rapid online triage of patients, and the sharing […]

Results from a Phase III trial show promise for patients with advanced breast cancer. Enhertu has been shown to reduce the risk of disease progression or death by 72% vs. trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer. Phase III head-to-head DESTINY-Breast03 results featured at ESMO Presidential Symposium support Enhertu as the potential new standard […]